Pages that link to "Q35220270"

The following pages link to Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele (Q35220270):

Displaying 34 items.

• A path forward for the chlamydial virulence factor CPAF (Q27014318) (← links)
• A T cell epitope-based vaccine protects against chlamydial infection in HLA-DR4 transgenic mice. (Q30558032) (← links)
• CCL5 regulation of mucosal chlamydial immunity and infection (Q33359789) (← links)
• Chlamydial protease-like activity factor--insights into immunity and vaccine development (Q33584064) (← links)
• Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice (Q33627084) (← links)
• Chlamydial protease-like activity factor mediated protection against C. trachomatis in guinea pigs (Q33740057) (← links)
• Heat denatured enzymatically inactive recombinant chlamydial protease-like activity factor induces robust protective immunity against genital chlamydial challenge (Q33757531) (← links)
• Immunization with a combination of integral chlamydial antigens and a defined secreted protein induces robust immunity against genital chlamydial challenge. (Q34119450) (← links)
• The contribution of interleukin-12/interferon-gamma axis in protection against neonatal pulmonary Chlamydia muridarum challenge (Q34163335) (← links)
• CD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection (Q34177368) (← links)
• CPAF: a Chlamydial protease in search of an authentic substrate (Q34372321) (← links)
• Use of a Guinea pig-specific transcriptome array for evaluation of protective immunity against genital chlamydial infection following intranasal vaccination in Guinea pigs. (Q34680475) (← links)
• Characterization of humoral immune responses to chlamydial HSP60, CPAF, and CT795 in inflammatory and severe trachoma (Q34735317) (← links)
• Vaccination againstChlamydiaGenital Infection Utilizing the MurineC. muridarumModel (Q34739969) (← links)
• Antibody signature of spontaneous clearance of Chlamydia trachomatis ocular infection and partial resistance against re-challenge in a nonhuman primate trachoma model (Q34759137) (← links)
• A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice (Q34980175) (← links)
• A limited role for antibody in protective immunity induced by rCPAF and CpG vaccination against primary genital Chlamydia muridarum challenge. (Q35214742) (← links)
• Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection (Q35329016) (← links)
• Vaccination with the defined chlamydial secreted protein CPAF induces robust protection against female infertility following repeated genital chlamydial challenge (Q35546561) (← links)
• Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway (Q35634194) (← links)
• Tumor Necrosis Factor (TNF) Receptor Superfamily Member 1b on CD8+ T Cells and TNF Receptor Superfamily Member 1a on Non-CD8+ T Cells Contribute Significantly to Upper Genital Tract Pathology Following Chlamydial Infection (Q35837314) (← links)
• Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach (Q36314065) (← links)
• Vaginal chlamydial clearance following primary or secondary infection in mice occurs independently of TNF-α. (Q36672211) (← links)
• Chlamydia trachomatis infection: host immune responses and potential vaccines (Q37349713) (← links)
• Human leukocyte antigen (HLA)-B, DRB1, and DQB1 allotypes associated with disease and protection of trachoma endemic villagers (Q37368025) (← links)
• Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection (Q37376858) (← links)
• Identifying catalytic residues in CPAF, a Chlamydia-secreted protease (Q37401433) (← links)
• Towards a Chlamydia trachomatis vaccine: how close are we? (Q37820669) (← links)
• Update on Chlamydia trachomatis Vaccinology (Q37834874) (← links)
• Murine MicroRNA-214 regulates intracellular adhesion molecule (ICAM1) gene expression in genital Chlamydia muridarum infection (Q37841127) (← links)
• Development status and future prospects for a vaccine against Chlamydia trachomatis infection (Q37845958) (← links)
• Reducing the risk of Chlamydia trachomatis transmission: male circumcision or a female vaccine? (Q43416609) (← links)
• National Institute of Allergy and Infectious Diseases workshop report: "Chlamydia vaccines: The way forward". (Q44059220) (← links)
• Intranasal immunization with recombinant chlamydial protease-like activity factor attenuates atherosclerotic pathology following Chlamydia pneumoniae infection in mice (Q90562999) (← links)